As a leader of innovation in the diagnostics industry, Seegene will fulfill its responsibility for promptly and safely guiding the global community into
a future free from diseases including COVID-19.

Across all categories of disease, from drug resistance, cancer and genetic disorders to infectious diseases spanning respiratory/gastrointestinal/sexually transmitted infections and cervical cancer that are increasing worldwide in line with globalization, industrialization and national advancement, we will develop and deliver molecular diagnostics of exceptional quality to make health care more accessible for all.